tibolone has been researched along with trisequens in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hammar, M; Nathorst-Böös, J | 1 |
Coelingh Bennink, HJ; Dören, M; Holzgreve, W; Rübig, A | 1 |
Bilgen, I; Bilgin, O; Coşan Terek, M; Memiş, A; Ozşener, S; Oztekin, K; Sendağ, F | 1 |
2 trial(s) available for tibolone and trisequens
Article | Year |
---|---|
Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen.
Topics: Anabolic Agents; Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Libido; Middle Aged; Norethindrone; Norpregnenes; Sexual Behavior | 1997 |
Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Topics: Aged; Anabolic Agents; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endosonography; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Incidence; Middle Aged; Norethindrone; Norpregnenes; Prospective Studies; Tablets; Uterine Hemorrhage; Vagina | 1999 |
1 other study(ies) available for tibolone and trisequens
Article | Year |
---|---|
Mammographic density changes during different postmenopausal hormone replacement therapies.
Topics: Cyproterone Acetate; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Progesterone Congeners; Retrospective Studies; Time Factors | 2001 |